Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters

In pursuit of unsymmetrical precursors for the novel series of anthracenyl-isoxazole amide (AIM) antitumor agents, a series of substituted anthracenes were subjected to bromination and re-aromatization in our study, during which we solved four single crystal X-ray diffractometry (Sc-xrd) structures...

Full description

Bibliographic Details
Main Authors: Michael J. Campbell, Daniel A. Decato, Chun Li, Matthew J. Weaver, Nicholas R. Natale
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Crystals
Subjects:
Online Access:https://www.mdpi.com/2073-4352/14/3/256
_version_ 1797241503197691904
author Michael J. Campbell
Daniel A. Decato
Chun Li
Matthew J. Weaver
Nicholas R. Natale
author_facet Michael J. Campbell
Daniel A. Decato
Chun Li
Matthew J. Weaver
Nicholas R. Natale
author_sort Michael J. Campbell
collection DOAJ
description In pursuit of unsymmetrical precursors for the novel series of anthracenyl-isoxazole amide (AIM) antitumor agents, a series of substituted anthracenes were subjected to bromination and re-aromatization in our study, during which we solved four single crystal X-ray diffractometry (Sc-xrd) structures which we report herein. The C-9 nitrile oxide, after its reaction with bromine, was isolated, but when subjected to re-aromatization, it returned to the starting 10-bromo nitrile oxide <b>1</b>, which did provide an accurate crystal structure, with R = 0.018. The 10-halogenated 3-(9’-anthryl)-isoxazole esters were subjected to bromination and re-aromatization. Surprisingly, the yields obtained in the presence of the isoxazole were reasonably good (62–68% isolated yields), and the major diastereomers allowed for the characterization using Sc-xrd. The penta bromo product <b>2</b> showed a <i>trans</i>, <i>trans</i>, <i>cis</i> relationship for the four bromines on the A-ring of the anthracene, and we observed that for the unit cell, the atropisomers displayed a 1:1 ratio at the chiral axis between the isoxazole and anthrancene rings. Similarly, the 10-chloro <b>3</b> indicated a ratio of 1:1 at the chiral axis in the crystal structure. A base-induced re-aromatization afforded 3,10-dihalogenated analogues selectively in very good yields (X = Cl, 89%; X = Br 92%), of which the dibromo <b>4</b> was characterized using Sc-xrd. The improved yields of the unique diastereomeric bromination products suggested the consideration of a novel electrophilic aromatic substitution mechanism driven by the stereo-electronic environment, imposed by the isoxazole ester substituent. The promise of the application of this chemistry in the future development of AIM antitumor agents is suggested.
first_indexed 2024-04-24T18:24:21Z
format Article
id doaj.art-37917addf0fb4761a08ea47b67e1735b
institution Directory Open Access Journal
issn 2073-4352
language English
last_indexed 2024-04-24T18:24:21Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Crystals
spelling doaj.art-37917addf0fb4761a08ea47b67e1735b2024-03-27T13:32:30ZengMDPI AGCrystals2073-43522024-03-0114325610.3390/cryst14030256Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole EstersMichael J. Campbell0Daniel A. Decato1Chun Li2Matthew J. Weaver3Nicholas R. Natale4Medicinal Chemistry Graduate Program, University of Montana, Missoula, MT 59812, USAMedicinal Chemistry Graduate Program, University of Montana, Missoula, MT 59812, USADepartment of Chemistry, Ithaca College, 953 Danby Road, Ithaca, NY 14850, USAMedicinal Chemistry Graduate Program, University of Montana, Missoula, MT 59812, USAMedicinal Chemistry Graduate Program, University of Montana, Missoula, MT 59812, USAIn pursuit of unsymmetrical precursors for the novel series of anthracenyl-isoxazole amide (AIM) antitumor agents, a series of substituted anthracenes were subjected to bromination and re-aromatization in our study, during which we solved four single crystal X-ray diffractometry (Sc-xrd) structures which we report herein. The C-9 nitrile oxide, after its reaction with bromine, was isolated, but when subjected to re-aromatization, it returned to the starting 10-bromo nitrile oxide <b>1</b>, which did provide an accurate crystal structure, with R = 0.018. The 10-halogenated 3-(9’-anthryl)-isoxazole esters were subjected to bromination and re-aromatization. Surprisingly, the yields obtained in the presence of the isoxazole were reasonably good (62–68% isolated yields), and the major diastereomers allowed for the characterization using Sc-xrd. The penta bromo product <b>2</b> showed a <i>trans</i>, <i>trans</i>, <i>cis</i> relationship for the four bromines on the A-ring of the anthracene, and we observed that for the unit cell, the atropisomers displayed a 1:1 ratio at the chiral axis between the isoxazole and anthrancene rings. Similarly, the 10-chloro <b>3</b> indicated a ratio of 1:1 at the chiral axis in the crystal structure. A base-induced re-aromatization afforded 3,10-dihalogenated analogues selectively in very good yields (X = Cl, 89%; X = Br 92%), of which the dibromo <b>4</b> was characterized using Sc-xrd. The improved yields of the unique diastereomeric bromination products suggested the consideration of a novel electrophilic aromatic substitution mechanism driven by the stereo-electronic environment, imposed by the isoxazole ester substituent. The promise of the application of this chemistry in the future development of AIM antitumor agents is suggested.https://www.mdpi.com/2073-4352/14/3/256anthraceneatropisomerismaxial chiralitybrominationisoxazole
spellingShingle Michael J. Campbell
Daniel A. Decato
Chun Li
Matthew J. Weaver
Nicholas R. Natale
Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
Crystals
anthracene
atropisomerism
axial chirality
bromination
isoxazole
title Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
title_full Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
title_fullStr Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
title_full_unstemmed Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
title_short Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters
title_sort synthesis and structure of unsymmetrical anthracenyl isoxazole antitumor agents via the diastereoselective bromination of 3 9 anthryl isoxazole esters
topic anthracene
atropisomerism
axial chirality
bromination
isoxazole
url https://www.mdpi.com/2073-4352/14/3/256
work_keys_str_mv AT michaeljcampbell synthesisandstructureofunsymmetricalanthracenylisoxazoleantitumoragentsviathediastereoselectivebrominationof39anthrylisoxazoleesters
AT danieladecato synthesisandstructureofunsymmetricalanthracenylisoxazoleantitumoragentsviathediastereoselectivebrominationof39anthrylisoxazoleesters
AT chunli synthesisandstructureofunsymmetricalanthracenylisoxazoleantitumoragentsviathediastereoselectivebrominationof39anthrylisoxazoleesters
AT matthewjweaver synthesisandstructureofunsymmetricalanthracenylisoxazoleantitumoragentsviathediastereoselectivebrominationof39anthrylisoxazoleesters
AT nicholasrnatale synthesisandstructureofunsymmetricalanthracenylisoxazoleantitumoragentsviathediastereoselectivebrominationof39anthrylisoxazoleesters